Calcium citrate: a new biomaterial that can enhance bone formation in situ

Objective: To investigate the effect of a new biomaterial combining calcium citrate and recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone regeneration in a bone defect rabbit model. Methods: Totally 30 male New Zealand white rabbits were randomly and equally divided into calcium citra...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of traumatology Vol. 15; no. 5; pp. 291 - 296
Main Authors Li-ming, Wang, Wei, Wang, Xiu-cui, Li, Lei, Peng, Zhong-qin, Lin, Hua-zi, Xü
Format Journal Article
LanguageEnglish
Published China Elsevier B.V 01.10.2012
Department of Orthopaedic Surgery,Affiliated Hospital of Binzhou Medical College,Binzhou 256603,Shandong Province,China%Department of Orthopaedic Surgery,Second Affiliated Hospital of Wenzhou Medical College,Wenzhou 325000,China%Department of Respiratory Medicine,Yuying Children's Hospital Affiliated to Wenzhou Medical College,Wenzhou 325000,China%Department of Orthopaedic Surgery,Second Affiliated Hospital of Wenzhou Medical College,Wenzhou 325000,China
Trauma Center of the Affiliated Hospital of Hainan Medical College,Haikou 571100,China%Hospital of Integrated Traditional Chinese and Western Medicine of Wenzhou City,Wenzhou 325000,China
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To investigate the effect of a new biomaterial combining calcium citrate and recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone regeneration in a bone defect rabbit model. Methods: Totally 30 male New Zealand white rabbits were randomly and equally divided into calcium citraterhBMP-2 (CC-rhBMP-2) group and rhBMP-2 only group. Two 10 ram-long and 5 ram-deep bone defects were respectively created in the left and right femoral condyles of the rabbits. Subsequently 5 pellets of calcium citrate (10 mg) combined with rhBMP-2 (2 rag) or rhBMP-2 alone were implanted into the bone defects and compressed with cotton swab. Bone granules were obtained at 2, 4 and 6 weeks after procedure and received histological analysis. LSD t-test and a subsequent t-test were adopted for statistical analysis. Results: Histomorphometric analysis revealed newlyformed bones, and calcium citrate has been absorbed in the treatment group. The percent of newly formed bone area in femoral condyle in control group and CC-rhBMP-2 group was respectively 31.73%±1.26% vs 48.21%±2.37% at 2 weeks; 43.40%±1.65% vs 57.32%±1.47% at 4 weeks, and 51.32%±7.80% vs 66.74%±4.05% at 6 weeks (P〈0.05 for all). At 2 weeks, mature cancellous bone was observed to be already formed in the treatment group. Conclusion: From this study, it can be concluded that calcium citrate combined with rhBMP-2 signifcantly enhances bone regeneration in bone defects. This synthetic gelatin matrix stimulates formation of new bone and bone marrow in the defect areas by releasing calcium ions.
Bibliography:Bone morphogenetic protein-2;Biocompatible materials; Calcium citrate; Gelatin
Objective: To investigate the effect of a new biomaterial combining calcium citrate and recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone regeneration in a bone defect rabbit model. Methods: Totally 30 male New Zealand white rabbits were randomly and equally divided into calcium citraterhBMP-2 (CC-rhBMP-2) group and rhBMP-2 only group. Two 10 ram-long and 5 ram-deep bone defects were respectively created in the left and right femoral condyles of the rabbits. Subsequently 5 pellets of calcium citrate (10 mg) combined with rhBMP-2 (2 rag) or rhBMP-2 alone were implanted into the bone defects and compressed with cotton swab. Bone granules were obtained at 2, 4 and 6 weeks after procedure and received histological analysis. LSD t-test and a subsequent t-test were adopted for statistical analysis. Results: Histomorphometric analysis revealed newlyformed bones, and calcium citrate has been absorbed in the treatment group. The percent of newly formed bone area in femoral condyle in control group and CC-rhBMP-2 group was respectively 31.73%±1.26% vs 48.21%±2.37% at 2 weeks; 43.40%±1.65% vs 57.32%±1.47% at 4 weeks, and 51.32%±7.80% vs 66.74%±4.05% at 6 weeks (P〈0.05 for all). At 2 weeks, mature cancellous bone was observed to be already formed in the treatment group. Conclusion: From this study, it can be concluded that calcium citrate combined with rhBMP-2 signifcantly enhances bone regeneration in bone defects. This synthetic gelatin matrix stimulates formation of new bone and bone marrow in the defect areas by releasing calcium ions.
50-1115/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1008-1275
DOI:10.3760/cma.j.issn.1008-1275.2012.05.007